###begin article-title 0
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2</italic>
Association study of polymorphisms in synaptic vesicle-associated genes, SYN2 and CPLX2, with schizophrenia
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2</italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2</italic>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
The occurrence of aberrant functional connectivity in the neuronal circuit is one of the integrative theories of the etiology of schizophrenia. Previous studies have reported that the protein and mRNA levels of the synapsin 2 (SYN2) and complexin 2 (CPLX2) genes were decreased in patients with schizophrenia. Synapsin 2 and complexin 2 are involved in synaptogenesis and the modulation of neurotransmitter release. This report presents a study of the association of polymorphisms of SYN2 and CPLX2 with schizophrenia in the Korean population.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
Six single nucleotide polymorphisms (SNPs) and one 5-bp insertion/deletion in SYN2 and five SNPs in CPLX2 were genotyped in 154 Korean patients with schizophrenia and 133 control patients using direct sequencing or restriction fragment length polymorphism analysis. An intermarker linkage disequilibrium map was constructed for each gene.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Although there was no significant difference in the genotypic distributions and allelic frequencies of either SYN2 or CPLX2 polymorphisms between the schizophrenia and control groups, the two-way haplotype analyses revealed significant associations with the disease (P < 0.05 after Bonferroni correction). The three-way haplotype analyses also revealed a significant association of SYN2 with schizophrenia (P < 0.001 after Bonferroni correction).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
These results suggest that both SYN2 and CPLX2 may confer susceptibility to schizophrenia in the Korean population.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Schizophrenia is a severe, chronic mental illness affecting 0.5-1.5% of the general population worldwide [1]. The contribution of genetic factors to the vulnerability to schizophrenia has been well established by family, twin, and adoption studies that have suggested a significant heritability of approximately 50-70% [2]. Many studies have attempted to identify the allelic variants that confer susceptibility to the illness, but no single genes have been identified that produce a major effect on the vulnerability [3].
###end p 11
###begin p 12
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN1</italic>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 532 538 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX1 </italic>
###xml 556 562 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1030 1031 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1032 1033 1032 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1317 1319 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 385 390 <span type="species:ncbi:9606">human</span>
###xml 1148 1156 <span type="species:ncbi:9606">patients</span>
Recently the synaptic hypothesis of schizophrenia has gained attention by attributing the fundamental pathology of schizophrenia to the dysfunction of synaptic transmission involving various molecules [4]. Synapsins, a family of synaptic vesicle-associated phosphoproteins, play a crucial role in the regulation of neurotransmission, synaptogenesis, and neuronal plasticity [5]. Three human synapsin genes have been identified (SYN1, 2, and 3; OMIM 313440, 600755, and 602705) [6]. Complexin 1 and complexin 2, which are encoded by CPLX1 (OMIM 605032) and CPLX2 (OMIM 605033), respectively, and are also called synaphins, are pre-synaptic membrane proteins that preferentially bind to syntaxin within the SNARE (soluble N-ethylmaleimide-sensitive fusion attachment protein receptors) complex. These proteins are important regulators of transmitter release immediately preceding vesicle fusion [7]. Previous studies have demonstrated that the concentrations of synapsins and complexins are reduced in the brains of schizophrenics [8,9]. The expression levels of both synapsins were significantly decreased in the hippocampal tissue of schizophrenic patients [10]. The levels of synapsin 2 and complexin 2 mRNA were also significantly reduced in the prefrontal cortex, cerebellum, and hippocampus of schizophrenics [11-14].
###end p 12
###begin p 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 362 368 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 495 501 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
SYN2 was mapped to chromosome 3p25 [15], and CPLX2 is located on chromosome 5q35.3 (OMIM 605033). These loci were identified as potential regions conferring susceptibility to schizophrenia in diverse populations [16-18]. Based on their localization, well-established neurobiological roles, and expression patterns in schizophrenic patients, we selected SYN2 and CPLX2 as candidate genes for conferring susceptibility to schizophrenia. In this report, we present an association study of SYN2 and CPLX2 with schizophrenia using 12 polymorphisms in the Korean population.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
SYN2 polymorphisms in the schizophrenia and control groups
###end title 15
###begin p 16
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2</italic>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dde</italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 802 804 802 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 959 960 959 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
Of the seven polymorphisms in SYN2, rs2623873 (SYN2-1) is located in the promoter region, whereas the others are all located in the intronic regions (SYN2-2-7) (Fig. 1, Table 1). The genotypic distributions and allelic frequencies of polymorphisms in SYN2 were determined in 113 schizophrenic patients and 114 normal healthy controls by direct sequencing or DdeI RFLP. The genotypic distributions and allelic frequencies of polymorphisms in SYN2 are shown in Table 2. The average allelic frequency of the SNPs was 0.312. Given the equivalent frequency for the susceptible allele, the expected detection power for SYN2 was 0.9538 to 0.9929 under the multiplicative model with a genotype relative risk = 1.8 to 2.0 [22]. None of the SNPs showed any significant deviation from Hardy-Weinberg equilibrium (P > 0.05). We observed no significant difference in the genotypic distributions and allelic frequencies between the schizophrenics and control groups (Table 2).
###end p 16
###begin p 17
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genomic organization of <italic>SYN2 </italic>and <italic>CPLX2 </italic>and locations of SNPs</bold>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
Genomic organization of SYN2 and CPLX2 and locations of SNPs. a; SYN2 spans over 140 kb and is composed of 14 exons. Seven markers are indicated with the dbSNP reference ID . b; CPLX2 spans over 83 kb and is composed 3 exons. Five markers are indicated with the dbSNP reference ID .
###end p 17
###begin p 18
Twelve polymorphisms genotyped in this study.
###end p 18
###begin p 19
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Timp4</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
a Tissue inhibitor of metalloproteinase 4 (Timp4) gene is nested within the intron of SYN2 in reverse orientation.
###end p 19
###begin p 20
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
Genotype distributions and allele frequencies of each polymorphism of the SYN2 and CPLX2 in the schizophrenia and control groups.
###end p 20
###begin p 21
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
a Fisher's exact probability tests, case vs controls (2 x 3 genotype-based analysis)
###end p 21
###begin p 22
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
b Fisher's exact probability tests, case vs controls (2 x 2 allele-based analysis)
###end p 22
###begin p 23
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 192 194 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 368 370 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 387 389 385 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 400 402 398 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 425 427 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 444 446 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 457 459 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 482 484 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 500 502 494 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 536 538 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 555 557 547 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 573 574 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 758 759 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 759 764 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 759 764 751 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 775 778 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 782 783 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 783 788 775 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 783 788 775 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 804 805 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1042 1043 1034 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
We compared the LD for all possible two-way comparisons of the SNPs in the controls (Table 3). The pairwise D' values for the seven SNPs were consistently high, except in one instance (SYN2-2 vs. SYN2-6; D' = 0.300, r2 = 0.200). Out of the 21 possible pairs of SNPs, significant haplotype associations with schizophrenia were observed for 4 pairs: SYN2-1 - SYN2-2 (chi2 = 27.58, df = 3, P = 4.45 x 10-6), SYN2-2 - SYN2-4 (chi2 = 16.46, df = 3, P = 9.12 x 10-4), SYN2-2 - SYN2-7 (chi2 = 8.08, df = 3, P = 0.044), and SYN2-3 - SYN2-4 (chi2 = 10.66, df = 3, P = 0.014) (Table 3). Even after the Bonferroni correction (number of haplotypes, n = 21), the associations of the SYN2-1 - SYN2-2 and SYN2-2 - SYN2-4 haplotypes with schizophrenia remained significant (Pcorr = 9.35 x 10-5 and Pcorr = 0.019) (Table 3). The T allele-the deletion allele haplotype for the SYN2-1 - SYN2-2 combination and the deletion allele-the G allele haplotype for the SYN2-2 - SYN2-4 combination were observed more frequently in schizophrenia than the controls (Table 4).
###end p 23
###begin p 24
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2</italic>
Pairwise linkage disequilibrium and haplotype association of SNPs in SYN2.
###end p 24
###begin p 25
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 64 66 64 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 75 78 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#967;</italic>
###xml 78 80 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Upper diagonal top: D', bottom: r2 in controls; Lower diagonal: P value by chi2 test (df = 3)
###end p 25
###begin p 26
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 2 4 2 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
a P < 0.05 after Bonferroni correction
###end p 26
###begin p 27
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2</italic>
Estimated haplotype frequencies of the SYN2-1 - SYN2-2 and SYN2-2 - SYN2-4 combination on the SYN2
###end p 27
###begin p 28
###xml 234 236 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 252 253 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 253 258 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 253 258 251 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 268 270 266 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
We also investigated the association of three-way haplotypes formed by SYN2-1, SYN2-2, and SYN2-4 with schizophrenia. A significant difference in the haplotype frequencies between the schizophrenia and control groups was observed (chi2 = 35.0, df = 7, Pcorr = 1.1 x 10-5). For the combination of SYN2-1, SYN2-2, and SYN2-4, the estimated frequencies of the T-deletion-G haplotype differed between the schizophrenia (0.570) and controls groups (0.440).
###end p 28
###begin title 29
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
CPLX2 polymorphisms in schizophrenia and control groups
###end title 29
###begin p 30
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2</italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 610 616 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 952 953 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 296 304 <span type="species:ncbi:9606">patients</span>
Of the five SNPs in CPLX2, rs2247916 (CPLX2-1) is located in the promoter region, rs2243404 (CPLX2-2) is located in the 5'UTR, and the others are located in the intronic regions (Fig. 1, Table 1). We determined the genotypic distributions and allelic frequencies of the SNPs in 154 schizophrenic patients and 133 normal healthy controls by direct sequencing or RFLP analysis. The genotypic distributions and allelic frequencies for CPLX2 SNPs are shown in Table 2. The average allelic frequency of the SNPs was 0.126. Given the equivalent frequency for the susceptible allele, the expected detection power for CPLX2 was 0.7445 to 0.8802 based on the multiplicative model with the genotype relative risk = 1.8 to 2.0 [22]. None of the five SNPs showed any significant deviations from Hardy-Weinberg equilibrium. We observed no significant differences in genotypic distributions or allelic frequencies between the schizophrenia and control groups (Table 2).
###end p 30
###begin p 31
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 183 185 183 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 209 211 209 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 252 254 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 331 333 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 350 352 348 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 409 410 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 410 415 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 410 415 408 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 430 431 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 598 599 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
We compared LD for all possible two-way comparisons of the SNPs in controls (Table 5). The pairwise D' values for the five SNPs were consistently low, except in one instance (CPLX2-2 vs. CPLX2-4; D' = 0.715, r2 = 0.011). Only one pair of SNPs (CPLX2-1 vs. CPLX2-2) showed a significant haplotype association with schizophrenia (chi2 = 16.28, df = 3, P = 0.0009), even after the Bonferroni correction (n = 10, Pcorr = 0.009, Table 5). For the combination of CPLX2-1 - CPLX2-2, the G allele-the C allele haplotype was observed more frequently in the schizophrenia group than the control group (Table 6).
###end p 31
###begin p 32
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2</italic>
Pairwise linkage disequilibrium and haplotype association of SNPs in CPLX2.
###end p 32
###begin p 33
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 64 66 64 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 75 78 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#967;</italic>
###xml 78 80 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Upper diagonal top: D', bottom: r2 in controls; Lower diagonal: P value by chi2 test (df = 3)
###end p 33
###begin p 34
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 2 4 2 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
a P < 0.01 after Bonferroni correction
###end p 34
###begin p 35
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2</italic>
Estimated haplotype frequencies of the CPLX2-1 - CPLX2-2 combination on the CPLX2
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 160 165 160 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 176 179 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 184 189 184 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 263 268 263 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">corr </italic>
###xml 403 408 403 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>corr </italic></sub>
###xml 418 420 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 858 860 858 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 884 886 884 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 924 926 924 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1035 1041 1035 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 1086 1088 1086 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1112 1114 1112 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1134 1135 1134 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
In this study, we observed significant, pairwise haplotype associations with schizophrenia for two pairs of SNPs in SYN2 (SYN2-1 - SYN2-2 and SYN2-2 - SYN2-4; Pcorr = 9.35 x 10-5 and Pcorr = 0.019, respectively) and one pair of SNPs in CPLX2 (CPLX2-1 - CPLX2-2, Pcorr = 0.009) (Table 3, 5). The three-way haplotype (SYN2-1, SYN2-2, and SYN2-4) also showed a significant association with schizophrenia (Pcorr = 1.1 x 10-5). The SYN2-1 and CPLX2-1 SNPs are located in the respective promoter regions, -98 and -156. SYN2-1 was located within the GC box motif and CPLX2-1 within the C/EBP motif in a database search . The positive haplotype associations seem to be based on an increase of LD in the schizophrenia group compared to the control group because the D' values of the schizophrenia group were higher than those of the controls [(SYN2-1 - SYN2-2, 0.935 vs. 0.531 (schizophrenics vs. controls)), (SYN2-2 - SYN2-4, 0.750 vs. 0.453)] (Table 3). A similar situation was also observed with the positive association of the haplotype in CPLX2 with schizophrenia [CPLX2-1 - CPLX2-2, 0.852 vs. 0.412 (schizophrenics vs. controls)] (Table 5).
###end p 37
###begin p 38
###xml 5 10 5 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
Chen et al. [23] recently reported an association study of four SNPs in SYN2 using Han Chinese samples. They found significant associations of SNP rs795009 and a haplotype constructed by the four SNPs with schizophrenia. Chen et al. [23] and our study examined two SNPs (rs2308169 and rs308963) in common, and their genotypic and allelic frequencies were similar in both studies. Although Chen et al. [23] did not mention the pairwise haplotype association study that we performed, they did report a significant difference in the overall four-way haplotype frequencies between schizophrenics and controls. Since two independent studies have reported a significant haplotype association of SYN2 with schizophrenia, this gene is probably involved in the pathogenesis of schizophrenia.
###end p 38
###begin p 39
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 855 856 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1070 1075 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 1079 1085 1079 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 477 485 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
###xml 1000 1008 <span type="species:ncbi:9606">patients</span>
Several studies have suggested that the decreased expression of synaptic genes is characteristic of schizophrenia. In the hippocampus of schizophrenic patients, several studies have shown a consistent pattern of decreases in presynaptic proteins and their encoding mRNAs, such as synapsin 2, synaptophysin, and synaptosomal-associated protein-25 (SNAP-25) [8-10,24]. Furthermore, a reduction in the synapsin 2 mRNA levels was observed in the prefrontal cortex of schizophrenic patients [14], but controvertible results have also been reported [25]. The altered expression levels of other presynaptic proteins, complexin 1 and complexin 2, have been reported in schizophrenic patients [11-13]. Interestingly, complexin 1 is enriched in axosomatic regions, inhibitor neurons, and their synapses, while complexin 2 is enriched in the axodendritic terminals [9,26]. The differential expression of complexins 1 and 2 implies their involvement in the excitatory synapse in the hippocampus of schizophrenic patients [11]. These observations suggest that abnormal expression of SYN2 and CPLX2 may cause the vulnerability to schizophrenia by altering neurotransmitter release and neuroplasticity.
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
We found significant differences in the haplotype frequencies in both SYN2 and CPLX2 polymorphisms between schizophrenia and control groups. In addition, the haplotype constructed from three polymorphisms (SYN2-1, SYN2-2, and SYN2-4) showed a significant association with schizophrenia. Our results suggest that both SYN2 and CPLX2 polymorphisms may contribute susceptibility to schizophrenia in the Korean population.
###end p 41
###begin title 42
Methods
###end title 42
###begin title 43
Subjects
###end title 43
###begin p 44
###xml 226 231 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 1127 1131 1115 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
###xml 797 805 <span type="species:ncbi:9606">patients</span>
A total of 154 unrelated Korean schizophrenia patients (80 male and 74 female with a mean +/- SD age of 43.8 +/- 11.4 yr) and 133 unrelated Korean controls (64 male and 69 female; age 50.6 +/- 11.7 yr) were recruited. For the SYN2 analysis, 113 unrelated Korean schizophrenia patients (60 male and 53 female with a mean +/- SD age of 42.2 +/- 11.3 yr) and 114 unrelated Korean controls (60 male and 54 female; age 51.7 +/- 10.9 yr) were participated. The schizophrenia patients were diagnosed using the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria. The control subjects were recruited after they had been designated as mentally healthy in a general health check-up program. The average age of the controls exceeded 50 years because we tried to avoid misincorporation of patients with late onset schizophrenia in the control group, while it may produce statistical bias potentially. Written informed consent was obtained from all subjects. This study was approved by the Ethics Committee of Kyung Hee University, Faculty of Medicine. Genomic DNA was extracted from whole blood cells using a NucleoSpin(R) Blood kit (Macherey-Nagel, Easton, PA).
###end p 44
###begin title 45
SNP Selection and PCR-based Genotyping
###end title 45
###begin p 46
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN2 </italic>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CPLX2 </italic>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 638 642 638 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 731 735 729 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 782 783 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Since the genomic sizes of SYN2 and CPLX2 are about 187 and 89 kb, respectively, we initially intended to select common polymorphisms at intervals of approximately 20-50 kb from the dbSNP . After validating the frequency of each polymorphism in 24 healthy Korean individuals using direct sequencing, we selected seven common polymorphisms from SYN2 and five from CPLX2 for further analyses (Fig. 1, Table 1). We amplified the fragments containing polymorphisms individually and genotyped DNA samples for each SNP with either PCR-based restriction fragment length polymorphism (RFLP) assays or direct sequencing performed with an ABI PRISM(R) Dye Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, CA) on an ABI PRISM(R) 3100 DNA sequencer (Applied Biosystems) (Table 1). In case of unclear sequence data, we repeated direct sequencing under various conditions until the genotype was determined correctly.
###end p 46
###begin title 47
Statistics
###end title 47
###begin p 48
###xml 327 329 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
The deviation of the genotypic frequencies from Hardy-Weinberg equilibrium was examined using the chi-square test (df = 1). Statistical differences in the genotypic distributions and allelic frequencies between the schizophrenia and control groups were examined using the Fisher's exact probability test. We calculated D' and r2 to evaluate the magnitude of linkage disequilibrium (LD) [19]. We estimated haplotype frequencies using the EH program, version 1.14 [20]. The statistical analysis of haplotype association was done as previously described [21]. We applied the Bonferroni correction to multiple testing based on the number of haplotypes. The significance level for all the statistical tests was 0.05.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
###xml 193 201 <span type="species:ncbi:9606">patients</span>
HJ Lee conceived of the study, carried out sequencing, participated in the interpretation of the data and drafted manuscript, JY Song, JW Kim and JK Park recruited the samples of schizophrenia patients, SY Jin, MS Hong, and J-H Chung recruited the samples of normal control, H Shibata and Y Fukumaki participated in its design, carried out the statistical analyses, and participated in the interpretation of data. All authors read and approved the final manuscript.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
This work was supported by JPSS and KOSEF, and in part by a grant of the Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea. (0405-NS01-0704-0001).
###end p 52
###begin article-title 53
Catching up on schizophrenia: natural history and neurobiology
###end article-title 53
###begin article-title 54
Schizophrenia
###end article-title 54
###begin article-title 55
The molecular genetics of schizophrenia: new findings promise new insights
###end article-title 55
###begin article-title 56
The synaptic hypothesis of schizophrenia
###end article-title 56
###begin article-title 57
Synapsins as regulators of neurotransmitter release
###end article-title 57
###begin article-title 58
Molecular evolution of the synapsin gene family
###end article-title 58
###begin article-title 59
SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis
###end article-title 59
###begin article-title 60
Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics
###end article-title 60
###begin article-title 61
Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
###end article-title 61
###begin article-title 62
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
###end article-title 62
###begin article-title 63
Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs
###end article-title 63
###begin article-title 64
Cerebellar synaptic protein expression in schizophrenia
###end article-title 64
###begin article-title 65
Molecular abnormalities of hippocampus in severe psychiatry illness: postmortem findings from the Stanley Neuropathology Consortium
###end article-title 65
###begin article-title 66
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
###end article-title 66
###begin article-title 67
###xml 21 26 <span type="species:ncbi:9606">human</span>
Associations between human disease genes and overlapping gene groups and multiple amino acid runs
###end article-title 67
###begin article-title 68
Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II: Schizophrenia
###end article-title 68
###begin article-title 69
Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes
###end article-title 69
###begin article-title 70
Genome-wide scan in Portuguese island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia
###end article-title 70
###begin article-title 71
###xml 70 75 <span type="species:ncbi:9606">human</span>
Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28
###end article-title 71
###begin article-title 72
Testing linkage disequilibrium between a disease gene and marker loci
###end article-title 72
###begin article-title 73
The analysis of allelic association
###end article-title 73
###begin article-title 74
The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers
###end article-title 74
###begin article-title 75
Positive association between synapsin II and schizophrenia
###end article-title 75
###begin article-title 76
###xml 40 48 <span type="species:ncbi:9606">patients</span>
SNAP-25 reduction in the hippocampus of patients with schizophrenia
###end article-title 76
###begin article-title 77
###xml 117 125 <span type="species:ncbi:9606">patients</span>
A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients
###end article-title 77
###begin article-title 78
Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses
###end article-title 78

